U.S. National Library of MedicineNational Institutes of Health
Skip navigation
MedlinePlus Trusted Health Information for You
Contact Us FAQs Site Map About MedelinePlus
español

Reuters Health Information Logo

IUDs seen to reduce cancer risk

Printer-friendly version Printer-friendly version

Reuters Health

Wednesday, May 7, 2008

WASHINGTON (Reuters) - Intrauterine devices are not only among the most effective contraceptives, but they also can help protect women from a cancer of the uterus called endometrial cancer, researchers reported on Tuesday.

Doctors often forget the devices, known commonly as IUDs, can treat endometriosis, Dr. David Grimes of Family Health International in Chapel Hill, North Carolina told a meeting of the American College of Obstetricians and Gynecologists in New Orleans.

"IUD use among women is associated with a 40 percent reduction in the risk of endometrial cancer, similar to the cancer protection provided by oral contraceptives, yet many clinicians are not aware of that," Grimes said in a statement.

"The IUD is underutilized as a contraceptive in the United States," he added. "Research is showing that it has health benefits far beyond preventing pregnancy."

An IUD is a small, T-shaped plastic device inserted into the uterus. Hormonal IUDs release small amounts of the hormone progestin, preventing pregnancy by preventing fertilization. The copper IUD releases small amounts of copper into the uterus to prevent pregnancy.

The hormones also help prevent endometrial cancer, a rare cancer of the lining of the uterus. Women who take contraceptive pills also have a lower risk of this disease.

"Only 2 percent of women who use contraception in the United States choose an IUD, despite the proven safety and effectiveness of this long-term contraception," said Grimes, who also teaches at the University of North Carolina in Chapel Hill.

"Worldwide, however, IUDs are the most widely used reversible contraceptive."


Reuters Health

Copyright © 2008 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.

Related News:
More News on this Date

Related MedlinePlus Pages: